Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Eptacog alfa (activated)

EU orphan designation number: EU/3/07/436
Active ingredient: Eptacog alfa (activated)
Indication: Treatment of post-neonatal intracerebral haemorrhage
Sponsor: Novo Nordisk A/S
Novo Allé, DK-2880 Bagsvaerd, Danmark

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/03/2007 Centralised Orphan - Designation EMEA/OD/089/06 (2007)1323 of 20/03/2007
23/06/2011 Centralised Orphan - Removal of orphan designation from Community Register